Linagliptin in the Management of Type 2 Diabetes Mellitus After Kidney Transplant-Reference-Cited by-同舟云学术

Linagliptin in the Management of Type 2 Diabetes Mellitus After Kidney Transplant

Published:2021-09 Issue:7 Volume:53 Page:2234-2237
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Attallah Nizar,Yassine Lina

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference29 articles.

1. US Renal Data System 2017 Annual Data Report: epidemiology of kidney disease in the United States;Saran;Am J Kidney Dis,2018

2. Diabetes mellitus after kidney transplantation in the United States;Kasiske;Am J Transplant,2003

3. Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years;Cosio;Kidney Int,2001

4. New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting;Davidson;Transplantation,2003

5. Posttransplant hyperglycemia. Increased incidence in cyclosporine-treated renal allograft recipients;Roth;Transplantation,1989

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early post-transplant hyperglycemia and post-transplant diabetes mellitus following heart transplantation;Expert Review of Endocrinology & Metabolism;2024-01-22

2. Sweet and simple as syrup: A review and guidance for use of novel antihyperglycemic agents for post‐transplant diabetes mellitus and type 2 diabetes mellitus after kidney transplantation;Clinical Transplantation;2023-02-13

3. Diabetes medication following heart transplantation: a focus on novel cardioprotective therapies—a joint review from endocrinologists and cardiologists;Acta Diabetologica;2022-12-20